Simon Waters

3PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersEnvironmental epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Dec 11, 2023
Comparison of Circulating Tumor DNA Assays for Molecular Residual Disease Detection in Early-Stage Triple-Negative Breast Cancer.

Maria Coakley, Guillermo Villacampa, Prithika Sritharan

|May 18, 2022
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial.

Francois-Clement Bidard, Virginia G Kaklamani, Patrick Neven

|Aug 12, 2021
Biomarker Analysis of the Phase III NALA Study of Neratinib + Capecitabine versus Lapatinib + Capecitabine in Patients with Previously Treated Metastatic Breast Cancer.

Cristina Saura, Judit Matito, Mafalda Oliveira

Pageof 1

Frequent Collaborators

1 joint publications

Cristina Saura

1 joint publications

Mafalda Oliveira

1 joint publications

Hans Wildiers

1 joint publications

Eduardo Cronemberger